Skip to main content

Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines.

Publication ,  Journal Article
Aronoff, GM; Brennan, MJ; Pritchard, DD; Ginsberg, B
Published in: Pain Med
2005

OBJECTIVE: To review the evidence for dosing and efficacy of oral transmucosal fentanyl citrate in the management of pain and produce dosing guidelines. DESIGN: The scientific literature pertaining to oral transmucosal fentanyl citrate was reviewed, focusing upon its pharmacology and clinical experience with use in cancer and noncancer pain. Emphasis was upon published, peer-reviewed English language articles. RESULTS: Information was crucially examined and synthesized into guidelines for use and dosing of oral transmucosal fentanyl citrate in cancer and noncancer pain. CONCLUSIONS: Oral transmucosal fentanyl citrate is a potent opioid delivery system, which, when used appropriately, is an effective treatment option for pain. Adherence to guidelines should promote its safe and efficacious use in a variety of clinical pain management settings.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pain Med

DOI

ISSN

1526-2375

Publication Date

2005

Volume

6

Issue

4

Start / End Page

305 / 314

Location

England

Related Subject Headings

  • Pain
  • Male
  • Humans
  • Guidelines as Topic
  • Fentanyl
  • Evidence-Based Medicine
  • Clinical Trials as Topic
  • Anesthesiology
  • Analgesics, Opioid
  • Administration, Oral
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Aronoff, G. M., Brennan, M. J., Pritchard, D. D., & Ginsberg, B. (2005). Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines. Pain Med, 6(4), 305–314. https://doi.org/10.1111/j.1526-4637.2005.00045.x
Aronoff, Gerald M., Michael J. Brennan, Douglas D. Pritchard, and Brian Ginsberg. “Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines.Pain Med 6, no. 4 (2005): 305–14. https://doi.org/10.1111/j.1526-4637.2005.00045.x.
Aronoff GM, Brennan MJ, Pritchard DD, Ginsberg B. Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines. Pain Med. 2005;6(4):305–14.
Aronoff, Gerald M., et al. “Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines.Pain Med, vol. 6, no. 4, 2005, pp. 305–14. Pubmed, doi:10.1111/j.1526-4637.2005.00045.x.
Aronoff GM, Brennan MJ, Pritchard DD, Ginsberg B. Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines. Pain Med. 2005;6(4):305–314.

Published In

Pain Med

DOI

ISSN

1526-2375

Publication Date

2005

Volume

6

Issue

4

Start / End Page

305 / 314

Location

England

Related Subject Headings

  • Pain
  • Male
  • Humans
  • Guidelines as Topic
  • Fentanyl
  • Evidence-Based Medicine
  • Clinical Trials as Topic
  • Anesthesiology
  • Analgesics, Opioid
  • Administration, Oral